Genenta Science S.p.A.
Price Action
Technical Summary
CONSOLIDATINGGenenta Science S.p.A. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 94), indicating clear outperformance against the broad market. Earnings growth of 52% provides fundamental context to the price action. However, price is extended 60% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.81 | +0.08% | ABOVE |
| 50 SMA | $1.13 | +60.18% | ABOVE |
| 100 SMA | $0.97 | +86.41% | ABOVE |
| 150 SMA | $1.16 | +56.71% | ABOVE |
| 200 SMA | $1.61 | +12.51% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is GNTA in an uptrend right now?
GNTA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is GNTA overbought or oversold?
GNTA's RSI (14) is 56. The stock is in neutral territory, neither overbought nor oversold.
Is GNTA outperforming the market?
GNTA has a Relative Strength (RS) Rating of 94 out of 99. Yes, GNTA is a market leader, outperforming 94% of all stocks over the past 12 months.
Where is GNTA in its 52-week range?
GNTA is trading at $1.81, which is 18% of its 52-week high ($10.00) and 13% above its 52-week low ($0.56).
How volatile is GNTA?
GNTA has a Beta of 1.32 and 52-week volatility of 161%. It's more volatile than the S&P 500 - expect bigger swings.